Outlook Therapeutics (OTLK) Stock: Buy, Sell, or Hold?
OTLK - Outlook Therapeutics, Inc. Common Stock
$0.57
-0.02 (-3.95%)
▼
5d:
-8.58%
30d:
-14.18%
90d:
-66.15%
WAIT
LOW Confidence
Analysis Updated: Oct 6, 2026 12:00 AM ET
Earnings: Aug 14, 2026
0d
Get Alerted When OTLK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OTLK shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OTLK shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: OTLK is currently trading at $0.57, which is considered oversold relative to its 30-day fair value range of $0.61 to $0.67.
Technical Outlook: Technically, OTLK is in a uptrend. Immediate support is located at $0.53, while resistance sits at $0.70. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.03 (+778.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OTLK is in a uptrend. Immediate support is located at $0.53, while resistance sits at $0.70. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.03 (+778.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.61 -
$0.67
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 778.5% below Wall St target ($5.03)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.61 -
$0.67
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.53
Resistance Level
$0.70
Current Trend
Uptrend
Technical data as of
Oct 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.77
Wall Street Target
$5.03
(+778.5%)
Revenue Growth (YoY)
-99.4%
Share & Embed Analysis
Last updated: October 07, 2026 6:22 AM ET
Data refreshes hourly during market hours. Next update: 7:22 AM
Data refreshes hourly during market hours. Next update: 7:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OTLK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 63 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
27 analysts |
$853 | 58 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
19 analysts |
$644 | 64 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$32 | 57 HOLD |
